Category: Uncategorized

Early Bird Registration for the MDA Conference Closes Soon

December 5, 2018 Early Bird Registration for the MDA Conference Closes Soon Even though it’s winter here in the US, spring is just around the corner. In April, clinical providers and researchers will meet for the first combined MDA Clinical and Research Conference in Orlando, Florida. This five day conference is your opportunity to learn… Read more »

Frequently Asked Questions: How do You Work with Clients?

November 14, 2018 Frequently Asked Questions: How do You Work With Clients? TRiNDS is a specialized neuromuscular contract research organization offering expert level support for clinical trials, post marketing studies, and academic research. Our clients are biopharmaceutical companies working to develop new treatments for neuromuscular disorders around the world. Our approach is to work in… Read more »

New Supplements: Duchenne Muscular Dystrophy Care Guidelines

November 9, 2018 New Supplements: Duchenne Muscular Dystrophy Care Guidelines The October 2018 issue of Pediatrics included a set of critical documents for the good care of children with Duchenne Muscular Dystrophy (DMD). The special supplement included a series of 12 articles outlining best practices for multidisciplinary management of DMD. These articles build on the… Read more »

Happy Fall from the TRiNDS Team!

    October 31, 2018 Happy Fall from the TRiNDS Team! Last week, TRiNDS staff travelled to beautiful Central Pennsylvania from all over the country for our annual retreat. We spent two days together to review our company progress, update our annual training, and to plan for the future. We did take some time for… Read more »

FDA Invites Public Comment On Adaptive Designs

October 25, 2018 FDA Invites Public Comment On Adaptive Designs The Food and Drug Administration (FDA) released an updated draft guidance to industry in early October entitled, “Adaptive Designs for Clinical Trials of Drugs and Biologics: Guidance for Industry.” The draft guidance reviews best practices for trial design, analysis, and reporting of clinical trials using… Read more »

Newborn Screening Update for Duchenne Muscular Dystrophy

October 18, 2018 Newborn Screening Update for Duchenne Muscular Dystrophy The Duchenne muscular dystrophy (DMD) community took two big steps toward newborn screening this month. Newborn screening programs are important because they allow early diagnosis even before symptoms are observed. Newborn screening facilitates early treatment and rapid development of new therapies for infants everywhere. When… Read more »

News

Building Your Team: Becker Muscular Dystrophy

October 3, 2018 Building Your Team: Becker Muscular Dystrophy Next week is Becker Muscular Dystrophy (BMD) Awareness Week, a time for everyone to recognize the families around the world living with BMD. BMD affects 1 in 35,000 males worldwide. People with BMD show symptoms of muscle weakness in the teen years and can often keep… Read more »